about
A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min MiceOxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling.Extracellular vesicles derived from renal cancer stem cells induce a pro-tumorigenic phenotype in mesenchymal stromal cells.Persistently elevated osteopontin serum levels predict mortality in critically ill patients.The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.Wogonin suppresses osteopontin expression in adipocytes by activating PPARαOsteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationGenetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resectionOPN-a induces muscle inflammation by increasing recruitment and activation of pro-inflammatory macrophages.Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis.Role of osteopontin in osteosarcoma.Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review.Osteopontin -- a promising biomarker for cancer therapy.Osteopontin polymorphism increases gastric precancerous intestinal metaplasia susceptibility in Helicobacter pylori infected male.Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies.Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties.Osteopontin at the Crossroads of Inflammation and Tumor Progression.Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer.Osteopontin-integrin α(v)β(3) axis is crucial for 5-fluorouracil resistance in oral squamous cell carcinoma.Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal CancerTumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis.Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway.Differential osteopontin expression in human osteoblasts derived from iliac crest and alveolar bone and its role in early stages of angiogenesis.Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex.Evaluation of osteopontin expression in chronic wounds: a potential prognostic and therapeutic biomarker.Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway.SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling.The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.The role of osteopontin in the progression of solid organ tumour.Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer
P2860
Q30384899-570E945D-9FF3-41AF-9971-BE0CD7FE8302Q33755325-34B4A0E2-1A9C-4DA9-9A4D-E003749EF38CQ34980734-71DAFF7D-3A7F-4131-8096-2C8DC1C72DB2Q35781475-074D4FF6-1DA5-47F2-A86E-E462EC0D711AQ35814641-2FB8B70D-44D1-4D96-803E-3B1B58094FEDQ35909530-ECDC98DB-B8BB-49C2-B106-4F28B91D724EQ36044802-A294046B-E7FB-40CE-8094-479ADAB5D4F1Q36160473-29D84B96-219A-471C-BACC-CF0C9BEBCE44Q36295223-AB03F641-C212-406A-82F5-E5CC8B7FB2CEQ36311002-F46FE6AB-92ED-4096-ABAB-AF9F20C416B4Q36578825-9E5B5EF2-4427-4FC1-9EFB-951082C70250Q36782301-CFE8F9E8-570A-4588-8F78-FC7C82A285F5Q37269227-D3C9C260-8347-4EE2-A09B-491FE523B72CQ37394133-01F282E6-79BF-4DAB-92A3-86B1AB4DA468Q37688419-C9832AC7-FA8B-4219-9EF4-0473C9829EFEQ38291427-FB52F307-C4E4-4D6E-B33C-20FA1D3162F0Q38445971-FACB134F-236E-4CD1-B153-8F1D665F69E9Q38619009-C322440B-FE72-4803-AFE2-0BE111691D56Q38661476-B2E8D505-3B67-4976-9EF4-F2B275C64437Q39253341-F51209E2-5661-4854-A77F-6821B1B90BC9Q39738927-E3689555-DFAD-4818-A3A0-18786C6DDE2AQ41099667-06F76EE6-8D03-420C-80EB-0EFB34096BC3Q41522574-A6D6BD6B-E269-410D-8244-5EF173C4B56BQ41702715-02F723CA-F3A7-4CAE-8A07-70ACAB84DBFDQ42539445-B47DBDED-F045-408C-BC43-F5669C6E7183Q45160477-3B86A484-414F-4F83-8EBA-B502ED6A6C01Q47196315-A56EB649-845B-4AD6-AC33-314F34907937Q47554433-0D8470F7-1EB8-4988-94F6-DE359522349CQ48011957-520A86BB-FFF4-4DC3-B14D-8D88B3387C29Q48021943-2C720128-0164-4452-9CF5-0E993F5AD941Q48217814-81780BB9-3393-4892-A9FA-F164A8DB97FFQ49502927-24CC4692-1CBA-4D4D-AC4A-54C449DD5B52Q49788190-015C0BF1-588F-46BD-8675-F1B839BABECBQ51734190-45731D45-F435-44BB-8DE8-F197ABD8A41BQ52608415-55CCEC54-B33D-44AF-BCA4-17FD8A8F42D0Q52676361-95C04732-F447-4A15-B9A3-6A313F8E2615Q55340253-C07C25AB-5C51-47FE-BF7C-E33AEDF68689Q57073431-B452C88B-4CC8-442D-AEAB-6E5E71F4C962
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Osteopontin as a therapeutic target for cancer.
@en
type
label
Osteopontin as a therapeutic target for cancer.
@en
prefLabel
Osteopontin as a therapeutic target for cancer.
@en
P2093
P2860
P50
P1476
Osteopontin as a therapeutic target for cancer.
@en
P2093
Amit S Yadav
Anuradha Bulbule
Dattatrya Shetti
Deepti Tomar
Dhanashri Thorat
Goutam Chakraborty
Gowrishankar Soundararajan
Kumar V S Totakura
Mahadeo Gorain
Monalisa Bandopadhyay
P2860
P304
P356
10.1517/14728222.2014.925447
P407
P577
2014-06-04T00:00:00Z